Skip to main content

Table 3 Secondary process measures and clinical outcomes pre-Intervention and during the study period

From: Impact of a chronic kidney disease registry and provider education on guideline adherence – a cluster randomized controlled trial

Variable Control clinic Intervention clinic
  Pre-intervention During the study period Pre-intervention During the study period
Last BP <130/80 mmHg 0.39 (0.33, 0.45) 0.41 (0.36, 0.46) 0.44 (0.38, 0.50) 0.44 (0.39, 0.49)
% of subjects with lab test in the last year     
 Phosphorus 0.66 (0.60, 0.72) 0.70 (0.66, 0.75) 0.59 (0.53, 0.65) 0.75 (0.71, 0.79)*
 Urine protein 0.72 (0.67, 0.78) 0.72 (0.67, 0.76) 0.56 (0.50, 0.62) 0.63 (0.58, 0.68)*
 Hemoglobin 0.82 (0.76, 0.86) 0.80 (0.76, 0.84) 0.85 (0.80, 0.89) 0.84 (0.79, 0.87)
Subjects on a diuretic 0.71 (0.66, 0.76) 0.68 (0.63, 0.72) 0.77 (0.72, 0.81) 0.75 (0.71, 0.79)
Subjects on an ACEI/ARB 0.81 (0.76, 0.85) 0.75 (0.71, 0.79)* 0.77 (0.72, 0.82) 0.78 (0.74, 0.82)
Subjects with diabetes or proteinuria on an ACEI/ARB 0.89 (0.84, 0.93) 0.85 (0.80, 0.89) 0.86 (0.78, 0.91) 0.88 (0.83, 0.92)
  1. * P value < 0.05 pre-intervention to study period within clinic.